BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lung cancer AND PMS1, hPMS1, 5378, ENSG00000064933, PMSL1, HNPCC3, DKFZp781M0253
21 results:

  • 1. Association of Reported Candidate Monogenic Genes With lung cancer Risk.
    Rifkin AS; Less EM; Wei J; Shi Z; Zheng SL; Helfand BT; Hulick PJ; Krantz SB; Xu J
    Clin Lung Cancer; 2023 Jun; 24(4):313-321. PubMed ID: 36781323
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Hypofractionated vs. conventional radiation therapy for stage III non-small cell lung cancer treated without chemotherapy.
    Iocolano M; Wild AT; Hannum M; Zhang Z; Simone CB; Gelblum D; Wu AJ; Rimner A; Shepherd AF
    Acta Oncol; 2020 Feb; 59(2):164-170. PubMed ID: 31608751
    [No Abstract]    [Full Text] [Related]  

  • 3. Role of evaluating tumor‑infiltrating lymphocytes, programmed death‑1 ligand 1 and mismatch repair proteins expression in malignant mesothelioma.
    Losi L; Bertolini F; Guaitoli G; Fabbiani L; Banchelli F; Ambrosini-Spaltro A; Botticelli L; Scurani L; Baldessari C; Barbieri F; Cascinu S; Maiorana A
    Int J Oncol; 2019 Nov; 55(5):1157-1164. PubMed ID: 31545419
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Mismatch Repair Protein Defects and Microsatellite Instability in Malignant Pleural Mesothelioma.
    Arulananda S; Thapa B; Walkiewicz M; Zapparoli GV; Williams DS; Dobrovic A; John T
    J Thorac Oncol; 2018 Oct; 13(10):1588-1594. PubMed ID: 30056163
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. DNA mismatch repair deficiency in lung and oral cavity carcinomas: the role of histogenetic origin.
    Spetsotaki KN; Tsiambas E; Stamatelopoulos A; Fotiades PP; Kastanioudakis I; Tomos P; Ragos V
    J BUON; 2017; 22(3):606-609. PubMed ID: 28730763
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Germline mutations in DNA repair genes predispose asbestos-exposed patients to malignant pleural mesothelioma.
    Betti M; Casalone E; Ferrante D; Aspesi A; Morleo G; Biasi A; Sculco M; Mancuso G; Guarrera S; Righi L; Grosso F; Libener R; Pavesi M; Mariani N; Casadio C; Boldorini R; Mirabelli D; Pasini B; Magnani C; Matullo G; Dianzani I
    Cancer Lett; 2017 Oct; 405():38-45. PubMed ID: 28687356
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. A Histopathological Feature of EGFR-Mutated lung Adenocarcinomas with Highly Malignant Potential - An Implication of Micropapillary Element.
    Matsumura M; Okudela K; Kojima Y; Umeda S; Tateishi Y; Sekine A; Arai H; Woo T; Tajiri M; Ohashi K
    PLoS One; 2016; 11(11):e0166795. PubMed ID: 27861549
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. The clinicopathological and prognostic features of Chinese and Japanese inpatients with lung cancer.
    Gao Y; Zhang JF; Li QC; Liu JJ; Liu LL; Yang XF; Jiang HM; Zheng HC
    Oncotarget; 2016 Oct; 7(41):67425-67434. PubMed ID: 27608841
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Whole exome sequencing identifies driver mutations in asymptomatic computed tomography-detected lung cancers with normal karyotype.
    Belloni E; Veronesi G; Rotta L; Volorio S; Sardella D; Bernard L; Pece S; Di Fiore PP; Fumagalli C; Barberis M; Spaggiari L; Pelicci PG; Riva L
    Cancer Genet; 2015 Apr; 208(4):152-5. PubMed ID: 25850996
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Significance of folate receptor alpha and thymidylate synthase protein expression in patients with non-small-cell lung cancer treated with pemetrexed.
    Christoph DC; Asuncion BR; Hassan B; Tran C; Maltzman JD; O'Shannessy DJ; Wynes MW; Gauler TC; Wohlschlaeger J; Hoiczyk M; Schuler M; Eberhardt WE; Hirsch FR
    J Thorac Oncol; 2013 Jan; 8(1):19-30. PubMed ID: 23242435
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. [Comparative analysis of cytopathologic and histopathologic diagnosis in the transbronchial needle aspiration specimens].
    Li XJ; Zhao J; Wang P; Wu Q; Li JY; Wang J; Li XH
    Zhonghua Bing Li Xue Za Zhi; 2012 Jun; 41(6):400-4. PubMed ID: 22932409
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Does blood transfusion increase the chance of recurrence in patients undergoing surgery for lung cancer?
    Churchhouse AM; Mathews TJ; McBride OM; Dunning J
    Interact Cardiovasc Thorac Surg; 2012 Jan; 14(1):85-90. PubMed ID: 22108935
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Potentially functional polymorphisms in DNA repair genes and non-small-cell lung cancer survival: a pathway-based analysis.
    Dong J; Hu Z; Shu Y; Pan S; Chen W; Wang Y; Hu L; Jiang Y; Dai J; Ma H; Jin G; Shen H
    Mol Carcinog; 2012 Jul; 51(7):546-52. PubMed ID: 21739480
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Semiquantitative visual approach to scoring lung cancer treatment response using computed tomography: a pilot study.
    Gottlieb RH; Kumar P; Loud P; Klippenstein D; Raczyk C; Tan W; Lu J; Ramnath N
    J Comput Assist Tomogr; 2009; 33(5):743-7. PubMed ID: 19820504
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Polymorphism discovery in 62 DNA repair genes and haplotype associations with risks for lung and head and neck cancers.
    Michiels S; Danoy P; Dessen P; Bera A; Boulet T; Bouchardy C; Lathrop M; Sarasin A; Benhamou S
    Carcinogenesis; 2007 Aug; 28(8):1731-9. PubMed ID: 17494052
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. A double-blind, randomised, controlled Phase II trial of Heliox28 gas mixture in lung cancer patients with dyspnoea on exertion.
    Ahmedzai SH; Laude E; Robertson A; Troy G; Vora V
    Br J Cancer; 2004 Jan; 90(2):366-71. PubMed ID: 14735178
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. [Genomic alterations in preneoplastic lesions].
    Gemma A
    Gan To Kagaku Ryoho; 2002 Dec; 29(13):2451-7. PubMed ID: 12506466
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. High resolution deletion mapping reveals frequent allelic losses at the DNA mismatch repair loci hMLH1 and hMSH3 in non-small cell lung cancer.
    Benachenhou N; Guiral S; Gorska-Flipot I; Labuda D; Sinnett D
    Int J Cancer; 1998 Jul; 77(2):173-80. PubMed ID: 9650548
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Reduced expression of hMLH1 and hGTBP/hMSH6: a risk factor for head and neck cancer.
    Wei Q; Eicher SA; Guan Y; Cheng L; Xu J; Young LN; Saunders KC; Jiang H; Hong WK; Spitz MR; Strom SS
    Cancer Epidemiol Biomarkers Prev; 1998 Apr; 7(4):309-14. PubMed ID: 9568786
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Expression of five selected human mismatch repair genes simultaneously detected in normal and cancer cell lines by a nonradioactive multiplex reverse transcription-polymerase chain reaction.
    Wei Q; Guan Y; Cheng L; Radinsky R; Bar-Eli M; Tsan R; Li L; Legerski RJ
    Pathobiology; 1997; 65(6):293-300. PubMed ID: 9491849
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.